← Evidence map

ArticleTheranostics2025

TMTP1-modified nanocarrier boosts cervical cancer immunotherapy by eliciting pyroptosis.

Hanjie Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40303327